type 2 diabetes

By Dave Muoio 02:51 pm June 3, 2020
WellDoc's BlueStar chronic disease-management tool has picked up another 510(k) FDA clearance that will allow it to support adult Type 2 diabetes patients using long-acting basal insulin. The feature was announced by WellDoc this morning, but cleared by the agency in April, according to a listing on its website. The new capability takes the form of a new program within the prescription BlueStar...
By Dave Muoio 03:22 pm February 26, 2020
Type 2 diabetes patients who received a continuous glucose monitoring (CGM) system as part of a virtual diabetes clinic program improved their HbA1c and near-uniformly said they were comfortable self-inserting a sensor with guidance from a remote coach, according to study data presented by Onduo at an academic conference last weekend. Further, while more than half of the study’s nearly 600...
By Dave Muoio 10:52 am December 3, 2019
Dexcom continuous glucose monitor users and their caregivers found themselves in the dark this weekend when a key monitoring feature ceased to function with little to no warning. The feature, called Dexcom Follow, transmits an alert when a CGM user’s blood sugar reaches a dangerous level and is often used by parents monitoring their children’s condition. When unexpected issues brought down the...
By Dave Muoio 02:34 pm March 11, 2019
New research set to be presented next week at the American College of Cardiology’s 68th Annual Scientific Session describes how the camera on a smartphone could be used to screen for Type 2 diabetes. Diabetes is associated with changes to how blood flows through a person’s blood vessels, an effect that researchers from UCSF suggest could be used to detect early changes. By applying a deep...
By Jonah Comstock 01:26 pm March 11, 2019
At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes. The test, which has not undergone FDA clearance and does not purport to diagnose a condition, is designed to help people understand when they’re at a higher-than-normal risk for Type 2 diabetes so they can alter their lifestyle. To assist with the latter piece,...
By Dave Muoio 12:10 pm February 25, 2019
Earlier this month, Hygieia’s d-Nav Insulin Guidance Service — an app that titrates insulin doses for individual Type 2 diabetes patients, regardless of their regimen type — received 510(k) clearance from the FDA. The cloud-based service leverages proprietary algorithms, users’ individual blood glucose data and a small team of in-house health professionals to generate and deliver insulin dosage...
By Jonah Comstock 02:27 pm November 14, 2018
Diabetes management company Virta Health announced today that the company will offer its service to employers and health plans at 100 percent risk — that is, customers will only pay if the company succeeds in its goal of reversing Type 2 diabetes and getting patients off of expensive diabetes medications. “Whoever pays the healthcare bill today, we say to them, 'Wouldn’t it be awesome if we could...
By Dave Muoio 08:20 am October 9, 2018
Health2047, a technology innovation enterprise backed the American Medical Association, announced today the launch of its second spin out company. Called First Mile Care, the new entity will use its $2 million in seed funding to build a scalable platform for connecting people with prediabetes to coaches and demographic-appropriate behavior change guidance. First Mile Care’s platform is being...
By Jonah Comstock 08:00 am September 5, 2018
Correction: A previous version of this article failed to specify that the deal concerns Freestyle Libre Pro, rather than the consumer version, Freestyle Libre. Livongo Health, the digital chronic disease management company founded by former Allscripts CEO Glen Tullman, announced today that it will be the first United States enterprise diabetes management company to bring Abbott’s Freestyle Libre...
By Dave Muoio 04:26 pm June 20, 2018
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension. Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the...